Global Veterinary Reference Laboratory market is expected to cross USD 8.65 Billion market size by 2031.
Global Veterinary reference Laboratory form the scientific backbone of advanced animal diagnostics, providing specialized analytical services that extend beyond the capabilities of routine veterinary clinics and in-house Laboratory. These facilities are equipped with sophisticated instrumentation and standardized quality systems to perform complex examinations that support disease diagnosis, therapeutic monitoring, epidemiological investigations, food safety programs, breeding management, pharmaceutical research, and regulatory surveillance. Modern reference Laboratory routinely process thousands of biological specimens each day, including blood, serum, plasma, tissue, fecal material, urine, milk, swabs, and post-mortem samples collected from companion animals, livestock, poultry, equine species, aquatic animals, and wildlife. According to the research report, “Global Veterinary Reference Laboratory Market Overview, 2031” published by Bonafide Research, the Global Veterinary Reference Laboratory market is expected to cross USD 8.65 Billion market size by 2031, with 8.89% CAGR by 2026-31.Establishing a fully operational reference laboratory requires substantial capital investment, with expenditures for analytical instrumentation, molecular platforms, laboratory automation, biosafety infrastructure, digital information systems, and quality assurance programs often ranging from US$1 million to more than US$10 million, depending on laboratory size, testing capacity, and accreditation requirements. High-end diagnostic platforms such as next-generation sequencing systems, automated immunoassay analyzers, mass spectrometers, and digital pathology scanners individually represent investments ranging from tens of thousands to several hundred thousand US dollars. The industry has also witnessed a notable shift toward centralized laboratory networks capable of handling high-volume testing while maintaining standardized analytical performance across multiple locations. International organizations, including the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO), continue to emphasize laboratory strengthening as a critical component of animal disease preparedness and cross-border health surveillance. Flanked by 2024 and 2026, increasing adoption of digital laboratory management systems, automated sample tracking, and integrated reporting platforms has improved laboratory efficiency, strengthened traceability, and supported compliance with evolving quality and biosafety standards. As veterinary medicine becomes increasingly data-driven, reference Laboratory are expanding their role from diagnostic service providers to scientific institutions supporting clinical excellence, research innovation, disease intelligence, and national animal health infrastructure. The veterinary reference laboratory industry operates within a highly interconnected ecosystem that combines scientific expertise, advanced laboratory infrastructure, specialized logistics, and rigorous quality management to deliver reliable diagnostic information across diverse animal health applications. Every stage of laboratory operation from sample collection and preservation to transportation, accessioning, analytical testing, validation, interpretation, and digital reporting relies on standardized operating procedures designed to maintain specimen integrity and analytical accuracy. Cold-chain logistics have become an essential operational requirement, particularly for molecular, microbiological, and histopathological examinations, where sample stability directly influences diagnostic quality. Laboratory Information Management Systems (LIMS) now serve as the operational foundation of many reference Laboratory, enabling automated workflow management, barcode-based specimen identification, secure data storage, and seamless integration with veterinary practice software. Accreditation under internationally recognized quality frameworks, including ISO/IEC 17025, together with national veterinary laboratory standards, has become increasingly important for Laboratory supporting regulatory testing, international animal trade, and pharmaceutical studies. Investment priorities across the industry continue to focus on laboratory modernization, cybersecurity, high-capacity analytical equipment, robotic sample handling, and digital pathology infrastructure, reflecting the growing importance of operational resilience and standardized reporting. Specialized Laboratory frequently maintain biorepositories containing thousands of archived biological specimens that support retrospective disease investigations, epidemiological studies, and biomarker research. Collaboration has also expanded between reference Laboratory, veterinary universities, government agencies, pharmaceutical manufacturers, and biotechnology companies to strengthen diagnostic validation, surveillance programs, and clinical research activities. Advances in cloud computing, artificial intelligence-assisted image assessment, genomic data management, and automated quality control are progressively enhancing laboratory productivity while supporting increasingly complex diagnostic workflows.
to Download this information in a PDF
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample| By Service Type | Clinical Chemistry | |
| Hematology | ||
| Immunodiagnostics | ||
| Molecular Diagnostics | ||
| Others | ||
| By Application | Disease Diagnosis & Monitoring | |
| Preventive & Wellness Testing | ||
| Toxicology & Therapeutic Drug Monitoring | ||
| Productivity & Reproductive Testing | ||
| Genetic & Breeding Testing | ||
| Other Applications | ||
| By Animal Type | Companion Animals | |
| Livestock Animals | ||
| By End User | Veterinary Hospitals and Clinics | |
| Research Institutes | ||
| In-House Laboratories | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Russia | ||
| Asia-Pacific | China | |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| South America | Brazil | |
| Argentina | ||
| Colombia | ||
| MEA | United Arab Emirates | |
| Saudi Arabia | ||
| South Africa | ||
Clinical chemistry dominates due to its routine application in veterinary health screening, organ function assessment, disease monitoring, and broad usage across companion animals and livestock diagnostics. Clinical chemistry represents the largest segment of the global veterinary reference laboratory market because it serves as a fundamental diagnostic tool used across almost every veterinary healthcare setting. These tests provide essential insights into biochemical parameters such as liver enzymes, kidney function indicators, glucose levels, electrolytes, proteins, and metabolic conditions, making them a standard component of veterinary examinations. Unlike specialized diagnostic categories that are used for specific conditions, clinical chemistry testing is performed routinely for preventive healthcare, disease detection, treatment monitoring, and pre-operative evaluations. The widespread presence of clinical chemistry analyzers in veterinary clinics, hospitals, and reference Laboratory has contributed to its strong market position. In companion animal healthcare, blood chemistry panels are frequently conducted for dogs and cats to identify chronic conditions, age-related disorders, and internal organ abnormalities. In livestock management, clinical chemistry supports herd health assessment, nutritional evaluation, and disease investigation for cattle, poultry, and other agricultural animals. The segment benefits from established laboratory infrastructure, standardized testing procedures, and high sample volumes generated through routine veterinary visits. Companies including IDEXX Laboratory, Zoetis, Heska, and Thermo Fisher Scientific provide automated chemistry analyzers and diagnostic platforms that are widely integrated into veterinary practices globally. Additionally, the availability of cost-effective testing panels and compatibility with both in-house and centralized reference laboratory models has strengthened adoption. The combination of frequent testing requirements, diverse animal applications, and integration into standard veterinary workflows has positioned clinical chemistry as the largest diagnostic segment worldwide. Genetic and breeding testing is expanding rapidly due to increasing adoption of genomic selection, inherited disease screening, and precision breeding practices across animal healthcare and agriculture. Genetic and breeding testing is emerging as the fastest-growing segment in the global veterinary reference laboratory market due to the increasing integration of genomic technologies into animal health management and breeding programs. These tests provide detailed genetic information related to inherited diseases, breed characteristics, parentage verification, reproductive performance, and desirable biological traits, enabling more informed decisions for both companion animals and livestock. In companion animal healthcare, genetic testing has gained importance among pet owners and breeders seeking early identification of hereditary disorders and improved breeding outcomes. DNA-based screening allows breeders to identify carriers of genetic conditions and reduce the transmission of inherited diseases in future generations. For livestock producers, genomic testing supports selective breeding programs by identifying animals with improved productivity, disease resistance, fertility characteristics, and superior genetic traits. The advancement of next-generation sequencing technologies, improved laboratory capabilities, and reduced genomic testing costs have expanded accessibility across veterinary applications. Agricultural sectors in countries such as the United States, Australia, Brazil, and European nations increasingly utilize genomic tools for livestock improvement and breeding optimization. Companies including Zoetis, Neogen, and Thermo Fisher Scientific have developed specialized veterinary genetic testing solutions covering multiple animal species. The growing focus on precision animal management, sustainable livestock production, and personalized veterinary care is further supporting adoption. As genomic analysis provides long-term insights beyond conventional diagnostic methods, genetic and breeding testing is becoming an important component of modern veterinary laboratory services. Companion animals lead globally due to rising pet healthcare expenditure, increasing preventive veterinary visits, and growing adoption of advanced diagnostic services for dogs and cats. The companion animals segment represents the largest and fastest-growing application area in the global veterinary reference laboratory market, supported by increasing healthcare attention toward pets and the growing adoption of advanced veterinary services. Dogs and cats account for a significant share of diagnostic testing volumes due to frequent veterinary consultations, preventive healthcare programs, and demand for specialized medical procedures. Veterinary reference Laboratory provide a wide range of companion animal diagnostic services, including clinical chemistry, hematology, infectious disease testing, pathology, oncology diagnostics, allergy testing, and genetic analysis. Preventive health screening has become an important part of companion animal care, with veterinarians increasingly recommending routine laboratory evaluations to detect chronic conditions at early stages. The growing prevalence of age-related diseases, metabolic disorders, and cancer among pets has increased the requirement for specialized diagnostic testing. Developed markets such as North America and Europe represent major contributors due to high pet ownership levels and greater veterinary healthcare spending, while urban markets in Asia-Pacific are also adopting advanced companion animal diagnostics. Companies such as IDEXX Laboratory, Antech Diagnostics, Zoetis, and Mars Veterinary Health have established extensive veterinary diagnostic networks focused on companion animals. The segment’s rapid growth is also linked to the humanization of pets, where owners increasingly seek healthcare services comparable to human medical standards. Rising demand for preventive care, specialized treatments, and personalized veterinary medicine continues to strengthen the role of companion animals as the dominant application segment within the veterinary reference laboratory industry. In-house Laboratory are growing fastest due to demand for immediate diagnostic results, improved clinical efficiency, and increasing adoption of compact veterinary testing technologies. The in-house Laboratory segment is the fastest-growing segment in the global veterinary reference laboratory market as veterinary clinics and hospitals increasingly adopt internal diagnostic capabilities to improve service efficiency and patient management. In-house Laboratory allow veterinarians to perform essential diagnostic procedures within the clinic environment, reducing dependence on external sample transportation and enabling faster clinical decisions. Common in-house diagnostic solutions include hematology analyzers, chemistry analyzers, urinalysis systems, coagulation testing platforms, and rapid infectious disease detection tools. These technologies are particularly valuable in emergency care, critical cases, surgical preparation, and routine veterinary examinations where immediate access to test results supports timely treatment decisions. The expansion of corporate veterinary hospital networks and the availability of automated, user-friendly diagnostic instruments have accelerated adoption worldwide. Small and medium-sized veterinary practices are increasingly integrating compact laboratory systems to enhance service offerings and improve workflow management. Companies such as IDEXX Laboratory, Zoetis, Heska, and FUJIFILM have developed veterinary diagnostic platforms designed specifically for point-of-care and clinic-based testing environments. In-house Laboratory also support better integration between diagnostic results and electronic veterinary practice management systems, improving record maintenance and clinical monitoring. The shift toward faster, decentralized diagnostic services, combined with technological improvements in laboratory automation, has positioned in-house Laboratory as one of the most rapidly expanding segments within the global veterinary reference laboratory market.
to Download this information in a PDF
North America maintains a leading position in the veterinary reference laboratory market due to its advanced animal healthcare infrastructure, strong laboratory networks, high veterinary healthcare expenditure, and widespread adoption of specialized diagnostic services across companion animal and livestock sectors. North America represents one of the most technologically advanced veterinary diagnostic ecosystems, supported by a well-established network of commercial Laboratory, university-based diagnostic centers, specialty veterinary hospitals, and government-supported animal health institutions. The United States contributes the majority of regional activity due to its large companion animal population, extensive livestock industry, and strong presence of major veterinary diagnostic providers such as IDEXX Laboratory, Antech Diagnostics, and Zoetis Reference Laboratory. The country’s veterinary healthcare system benefits from organizations including the USDA Animal and Plant Health Inspection Service (APHIS) and the National Animal Health Laboratory Network (NAHLN), which strengthen laboratory coordination, disease monitoring, and quality standards. Canada supports regional development through established veterinary colleges, agricultural research facilities, and structured animal disease management programs. Increasing investments in specialty veterinary hospitals and advanced diagnostic facilities have improved access to complex laboratory testing services across the region. The United States and Canada also demonstrate strong adoption of automated laboratory workflows, digital reporting systems, and integrated veterinary software platforms due to higher healthcare spending and technological readiness. Continuous expansion of private veterinary networks and increasing collaboration between diagnostic companies, pharmaceutical firms, and research organizations further reinforce North America’s leadership within the veterinary reference laboratory landscape. Europe represents a highly developed veterinary reference laboratory market supported by strong regulatory frameworks, established animal health surveillance systems, advanced scientific capabilities, and a long history of laboratory-based disease management. Europe maintains a significant position in veterinary diagnostics due to its comprehensive approach toward animal health protection, food safety monitoring, and regulatory compliance. The region benefits from coordinated veterinary healthcare systems supported by government Laboratory, research institutions, universities, and private diagnostic networks. Countries such as Germany, France, the United Kingdom, the Netherlands, and Switzerland have developed advanced laboratory infrastructure capable of supporting livestock health programs, companion animal diagnostics, and research activities. The European Union’s Animal Health Law and coordinated disease surveillance initiatives provide a structured framework for laboratory testing, pathogen monitoring, and reporting requirements across member states. Germany remains one of the strongest contributors due to its advanced veterinary research ecosystem, strong livestock production base, and presence of specialized diagnostic organizations. The United Kingdom continues to maintain a mature veterinary laboratory environment through institutions such as the Animal and Plant Health Agency (APHA), supporting national disease monitoring and scientific research. France and the Netherlands demonstrate strong capabilities in agricultural diagnostics due to their extensive livestock industries and emphasis on food safety. Increasing attention toward antimicrobial resistance monitoring, laboratory quality standards, and scientific collaboration between countries continues to strengthen Europe’s veterinary reference laboratory ecosystem. Asia Pacific is expected to experience significant expansion in the veterinary reference laboratory market due to rapid modernization of animal healthcare systems, increasing livestock production, rising pet ownership, and growing investments in diagnostic infrastructure. Asia Pacific is emerging as a strategically important veterinary diagnostics market as countries across the region strengthen animal health systems and improve laboratory capabilities. China represents one of the largest contributors due to its extensive livestock population, expanding biotechnology sector, and increasing investment in animal disease prevention infrastructure. Government initiatives supporting agricultural modernization and food safety management have encouraged improvements in veterinary laboratory capacity. Japan maintains a highly developed veterinary healthcare ecosystem supported by advanced research institutions, sophisticated companion animal care services, and strong quality standards within diagnostic operations. The country’s aging human population and increasing pet ownership have contributed to greater demand for specialized veterinary healthcare services. India represents one of the fastest developing markets within the region, supported by its large livestock population, expanding private veterinary sector, and increasing focus on animal disease management. Government organizations such as the Indian Council of Agricultural Research (ICAR) and veterinary universities contribute to strengthening diagnostic capabilities across the country. Australia and South Korea also demonstrate strong potential through advanced agricultural systems, established veterinary research networks, and increasing adoption of modern diagnostic technologies. Although market maturity varies significantly between countries, improving healthcare infrastructure, biotechnology development, and expanding animal health awareness continue to support long-term regional growth. South America represents an emerging veterinary reference laboratory market supported by its large-scale livestock production base, export-oriented agricultural economy, and increasing need for reliable animal health monitoring systems. South America’s veterinary reference laboratory landscape is strongly influenced by the importance of livestock production, particularly cattle, poultry, and swine industries that contribute significantly to regional and international agricultural trade. Brazil dominates the regional market due to its position as one of the world’s largest producers and exporters of beef and poultry, creating substantial requirements for laboratory testing, disease verification, and animal health certification. The country has developed a broad veterinary diagnostic network involving government institutions, agricultural research organizations, universities, and private Laboratory to support livestock productivity and trade compliance. Argentina also maintains a strong position through its established cattle industry, agricultural research capabilities, and focus on maintaining international market standards. Countries such as Chile and Colombia are gradually improving veterinary diagnostic infrastructure through investments in agricultural modernization and food safety programs. The region continues to place greater importance on laboratory-supported disease management as producers seek to protect livestock assets and maintain access to global markets. However, veterinary laboratory development remains uneven due to differences in infrastructure availability, geographic challenges, and healthcare investment levels between countries. Increasing collaboration between public institutions, private diagnostic providers, and international organizations is helping improve laboratory capacity and accessibility across the region. The Middle East & Africa veterinary reference laboratory market is developing steadily as governments increase investment in animal healthcare infrastructure, food security programs, livestock management systems, and disease monitoring capabilities. The Middle East & Africa region is witnessing gradual advancement in veterinary diagnostic capabilities as countries prioritize animal health protection and agricultural sustainability. The Middle East demonstrates stronger market development due to higher healthcare investment capacity, modern veterinary facilities, and national programs focused on food security and livestock management. Saudi Arabia represents one of the leading markets in the region, supported by healthcare modernization initiatives under Vision 2030, increasing investment in veterinary services, and expansion of advanced agricultural systems. The United Arab Emirates is strengthening its position through private healthcare development, biotechnology investment, and the establishment of modern animal health facilities. In Africa, veterinary reference Laboratory play a critical role in supporting livestock-dependent economies, where animal health directly influences agricultural productivity and rural livelihoods. South Africa remains the most developed veterinary diagnostic market in Sub-Saharan Africa due to its established research institutions, commercial livestock sector, and stronger laboratory infrastructure. Organizations such as the African Union Interafrican Bureau for Animal Resources (AU-IBAR) contribute toward improving regional veterinary capacity and disease management programs. Despite differences in infrastructure maturity and specialist availability, increasing investment in veterinary education, laboratory modernization, and livestock development initiatives is gradually strengthening the region’s diagnostic ecosystem.
to Download this information in a PDF
• In January 2026, VolitionRx Limited announced partnerships with Midwest Veterinary Laboratory and Bioguard to expand access to its Nu.Q® Vet Cancer Test. Midwest Veterinary Laboratory will offer nationwide testing from February 2026, while Bioguard will provide services across Taiwan and China, strengthening early cancer detection through veterinary reference laboratory networks. • In June 2024, IDEXX Laboratory introduced the Catalyst Pancreatic Lipase Test, designed to provide quantitative results in under 10 minutes, aiding veterinarians in the rapid diagnosis and treatment of pancreatitis in dogs and cats • In May 2024, Mars, Incorporated entered exclusive discussions to acquire Cerba HealthCare’s stake in Cerba Vet and ANTAGENE, aiming to enhance its European veterinary diagnostics business through Mars Petcare’s Science & Diagnostics division • In January 2024, GD Animal Health, based in the Netherlands, acquired PathoSense diagnostics to advance its diagnostic capabilities, focusing on identifying all viruses and bacteria using nanopore sequencing technology • In February 2024, IDEXX Laboratory launched Vello, a pet owner engagement software solution designed to streamline connections between veterinary practices and clients. Vello integrates with IDEXX practice management software, offering features such as automated reminders, health service alerts, and a user-friendly mobile web platform for easy access to pet records and appointment scheduling

We are friendly and approachable, give us a call.